<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Surgical Oncology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24755359</article-id>
      <article-id pub-id-type="pmc">4000617</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-12-105</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-12-105</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Beltrame</surname>
            <given-names>Valentina</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>valebeltrame@libero.it</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Gruppo</surname>
            <given-names>Mario</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>mario.gruppo@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Pastorelli</surname>
            <given-names>Davide</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>davide.pastorelli@ioveneto.it</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Pizzi</surname>
            <given-names>Sara</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>sara.pizzi@sanita.padova.it</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Merigliano</surname>
            <given-names>Stefano</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>stefano.merigliano@unipd.it</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A6">
          <name>
            <surname>Sperti</surname>
            <given-names>Cosimo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>csperti@libero.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic, University of Padua, Giustiniani 2, 35128, Padua, Italy</aff>
      <aff id="I2"><label>2</label>Department of Oncology, Rare Tumors Unit, Veneto Institute of Oncology, Padua, Italy</aff>
      <aff id="I3"><label>3</label>Department of Pathology, University of Padua, Padua, Italy</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>4</month>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <fpage>105</fpage>
      <lpage>105</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Beltrame et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Beltrame et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.wjso.com/content/12/1/105"/>
      <abstract>
        <p>Primary extra-gastrointestinal stromal tumor (EGISTs) arising in the pancreas is extremely rare: only 20 cases have previously been reported in the English literature from 2000 to 2013. We reported a case of EGIST of the pancreas in a 69-year-old woman who presented with abdominal pain and with a solid, heterogeneously enhancing neoplasm in the uncinate process of the pancreas, revealed preoperatively by an abdominal computed tomography scan. A diagnosis of neuroendocrine tumor was suggested. Positron emission tomography with 68Ga-DOTATOC did not show pathological accumulation of the tracer in the pancreas. The patient underwent enucleation, under ultrasonic guidance, of the pancreatic tumor that emerged to the surface of the pancreas. Histopathology and immunohistochemical examination confirmed the final diagnosis of EGIST of the pancreas (CD117+), with one mitosis per 50 high-power fields. Although rarely, GIST can involve the pancreas as a primary site, and this tumor should be considered in the differential diagnosis of pancreatic neoplasms.</p>
      </abstract>
      <kwd-group>
        <kwd>Differential diagnosis</kwd>
        <kwd>Gastrointestinal stromal tumor</kwd>
        <kwd>Pancreas</kwd>
        <kwd>Pancreatectomy</kwd>
        <kwd>Pancreatic neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract, with an annual incidence of 10 to 20 per million [<xref ref-type="bibr" rid="B1">1</xref>]. GISTs are neoplasms arising from, or differentiating along, a line similar to the gastrointestinal pacemaker cells, the interstitial cells of Cajal (ICCs) [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. ICCs form a network around the myenteric plexus and within the muscolaris propriae of the gastrointestinal wall. GISTs may occur in the entire length of gastrointestinal tract from the esophagus to the anus; however, the most common sites are stomach (60%), small intestine (30%), rectum (5%), and esophagus (&lt;5%) [<xref ref-type="bibr" rid="B1">1</xref>]. Duodenal GISTs constitute 30% of primary duodenal tumors and less than 5% of gastrointestinal stromal tumors [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. Sometimes, these tumors may arise from the omentum, mesentery, gallbladder, and retroperitoneum, adjacent, but separate from the stomach and the intestine [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]; in this case the neoplasm is defined as &#x2018;extra-gastrointestinal stromal tumors&#x2019; (EGISTs). EGISTs do not display connection to the wall or the serosal surface of the viscera. EGISTs arising in the pancreas are extremely rare, and only 20 cases have been reported in the literature from 2000 to 2013 [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. We present a new case of a pancreatic EGIST misinterpreted as non-functioning endocrine tumor, in a 69-year-old woman. A review of the literature is also included.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 69-year-old woman presented in March 2013 with abdominal pain localized in the right hyphocondrium. There was no history of vomiting, gastrointestinal bleeding, jaundice, anorexia, or weight loss. Abdominal ultrasonography did not show pathologic features, but the pancreas was not clearly visualized. Contrast-enhanced computed tomography (CT) of the abdomen (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>) revealed a solid, hypervascular nodule in the uncinate process of the pancreas, measuring 22&#x2009;&#xD7;&#x2009;15&#xA0;mm. The possibility of a neuroendocrine tumor was considered; therefore she underwent Gallium-68 somatostatin receptor positron emission tomography (PET) (68Ga-DOTATOC), without evidence of neoplasms with pathologic expression of somatostatin receptors. Routine laboratory investigations, exocrine and endocrine serum markers, and hormonal panel were within normal limits, except for CEA: 5.7 ug/L ( reference value &lt;5 ug/L). Endoscopic ultrasound (EUS) confirmed a 2-cm hypoechoic tumor in the head of the pancreas; fine-needle aspiration of the lesion was not available at that moment. At laparotomy, in April 2013, a well-demarcated, red nodule was identified in the uncinate process of the pancreas; no attach with the duodenal wall was found. Intraoperative sonography showed that the 2-cm hypoechoic mass was separated from the main pancreatic duct. Careful enucleation of the tumor with Harmonic scalpel, under ultrasound guidance, was successfully performed. Pancreatic capsula was closed with interrupted, absorbable stitches. The postoperative course was uneventful, and the patient was discharged 7&#xA0;days after surgery. Macroscopic examination showed a 2.4&#xA0;cm well defined, ovoid mass. Microscopically, the tumor was composed of spindle cells, with focal atypia (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>). The mitotic count was one mitoses/50 high power fields (HPFs). Immunohistochemical examination showed neoplastic cells diffusely positive for antibodies against CD 117 (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>), focally positive for CD34 (Figure&#xA0;<xref ref-type="fig" rid="F4">4</xref>) and smooth muscle actin, while cells were negative for desmin. A diagnosis of pancreatic GIST with low risk of malignancy has been placed, pT2N0M0, stage I according to TNM (AJCC) classification [<xref ref-type="bibr" rid="B32">32</xref>]. On molecular genetic examination, deletion of three nucleotides in exon 11 of c-Kit was found. She did not receive any adjuvant therapy after surgery; 12&#xA0;months later she is in good general condition and there is no evidence of recurrent disease.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Abdominal CT scan showing a 2-cm, contrast-enhanced mass (arrow) in the uncinate process of the pancreas.</p>
        </caption>
        <graphic xlink:href="1477-7819-12-105-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Stromal tumor composed of spindle and epithelioid cells with focal vacuolar (signet ring) change. (E &amp; E, 20&#xD7;).</p>
        </caption>
        <graphic xlink:href="1477-7819-12-105-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Immunostain for c-KIT: strong and diffuse cytoplasmic immunoreactivity.</p>
        </caption>
        <graphic xlink:href="1477-7819-12-105-3"/>
      </fig>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Immunostain for CD34: focal immunoreactivity.</p>
        </caption>
        <graphic xlink:href="1477-7819-12-105-4"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>We reported a rare case of a primary pancreatic GIST: the small size, the well circumscribed margins of the lesion, and the contrast enhancement at CT examination suggested a diagnosis of neuroendocrine tumor of the pancreas. GISTs reported outside the gastrointestinal tract as apparent primary tumors are defined as &#x2018;extra-gastrointestinal stromal tumors&#x2019; (EGISTs). The concept of GIST has recently been established, due to the progress in immunohistochemical analyses. It is presumed that these tumors originate from the interstitial cells of Cajal (ICCs), pacemaker cells, which are present throughout the wall of the gastrointestinal tract and which regulate the motility. ICCs share many characteristics with EGISTs, including expression of CD117 and CD34 [<xref ref-type="bibr" rid="B2">2</xref>]. In fact, the most selective immunohistochemical markers differentiating GISTs from true smooth muscle tumors is the expression of the c-Kit receptor tyrosine kinase (CD117 antigen) in 95% of GISTs. In 2004, Yamamoto et al. [<xref ref-type="bibr" rid="B31">31</xref>] reported that EGISTs show similar KIT mutations of typical GISTs suggesting that these tumors have a similar origin. However, at present the origin of EGISTs remains controversial. Some authors believe that GISTs and EGISTs arise from the common precursor cell of ICCs and the smooth muscle cells of the gut, which may account for their growth within and outside the gastrointestinal tract [<xref ref-type="bibr" rid="B33">33</xref>]. Other, simpler, explanation suggests that EGISTs are in fact mural GISTs with extensive extramural growth, resulting in eventual loss of their connection with the gut wall [<xref ref-type="bibr" rid="B33">33</xref>].</p>
      <p>Pancreatic GISTs are extremely rare. We collected only 21 cases (including our patient) from the English literature: their clinicopathologic features and outcomes are summarized in Table&#xA0;<xref ref-type="table" rid="T1">1</xref>. The age of the patients ranges from 30 to 84&#xA0;years, with a mean age of 55.0&#xA0;years. The male:female ratio was 10:11. Ten of 21 (48%) tumors occurred in the head of the pancreas, five in the tail (34%), four involved both body and tail (19%), and two occurred in the uncinate process (%). EGIST rarely (<italic>n</italic>&#x2009;=&#x2009;1.5%) involved the entire pancreas [<xref ref-type="bibr" rid="B24">24</xref>]. There is a great variation in size (range, 2.4 to 34&#xA0;cm). The mitotic count was &lt;5/50 HPFs in eight cases (38%) and &gt;10/50 HPFs in four cases (19%). Molecular biology of EGIST has been investigated in only two reports [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B22">22</xref>] and in our patient: two exhibited deletion of base pairs in exon 11, and one showed DNA polymorphism of L862L in exon 18 of c-KIT gene [<xref ref-type="bibr" rid="B22">22</xref>]. All but one patient underwent surgery: one patient with metastatic disease died 5&#xA0;days after admission without operation. One patient underwent palliative operation (cystojejunostomy) and the remaining 17 patients underwent pancreatic resection (in 5 extended to adjacent organs), one had local resection, and one (our case) enucleation of the tumor. Follow-up was available in 19 cases. Disease recurrence following surgery was reported in five cases: three patients underwent re-resection and are alive and free after 30, 41, and 48&#xA0;months, respectively. Overall, 18 patients are alive with a median survival time of 17.5&#xA0;months (range, 1 to 66&#xA0;months). Despite the limited number of cases and the short follow-up time, it appears that resection of pancreatic GISTS may offer a good prognosis, even in recurrent disease.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Clinicopathologic features, treatment, and outcome of EGISTs reported in the English literature</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Author</bold>
              </th>
              <th align="center">
                <bold>Year</bold>
              </th>
              <th align="center">
                <bold>Age (years)</bold>
              </th>
              <th align="center">
                <bold>Sex</bold>
              </th>
              <th align="left">
                <bold>Site/Treatment</bold>
              </th>
              <th align="left">
                <bold>Size (cm)</bold>
              </th>
              <th align="left">
                <bold>Mitotic count (/50 HPF)</bold>
              </th>
              <th align="left">
                <bold>Follow-up, months</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Neto et al. [<xref ref-type="bibr" rid="B11">11</xref>]<hr/></td>
              <td align="center" valign="bottom">2004<hr/></td>
              <td align="center" valign="bottom">67<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Body and tail/DP&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">20<hr/></td>
              <td align="left" valign="bottom">120; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, Relapse, 1<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Yamaura et al. [<xref ref-type="bibr" rid="B12">12</xref>]<hr/></td>
              <td align="center" valign="bottom">2004<hr/></td>
              <td align="center" valign="bottom">54<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Tail/DP<hr/></td>
              <td align="left" valign="bottom">14<hr/></td>
              <td align="left" valign="bottom">Few; CD117(-) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 30<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Krska et al. [<xref ref-type="bibr" rid="B13">13</xref>]<hr/></td>
              <td align="center" valign="bottom">2005<hr/></td>
              <td align="center" valign="bottom">38<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Body and tail/DP<hr/></td>
              <td align="left" valign="bottom">17<hr/></td>
              <td align="left" valign="bottom">1; CD117(-) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 30<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Daum et al. [<xref ref-type="bibr" rid="B14">14</xref>]<hr/></td>
              <td align="center" valign="bottom">2005<hr/></td>
              <td align="center" valign="bottom">70<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Head/PD&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">10<hr/></td>
              <td align="left" valign="bottom">2; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">A, NED, 6<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Showalter et al. [<xref ref-type="bibr" rid="B15">15</xref>]<hr/></td>
              <td align="center" valign="bottom">2008<hr/></td>
              <td align="center" valign="bottom">72<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Tail/DP<hr/></td>
              <td align="left" valign="bottom">7<hr/></td>
              <td align="left" valign="bottom">3; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">A, NED, 27<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Yan et al. [<xref ref-type="bibr" rid="B16">16</xref>]<hr/></td>
              <td align="center" valign="bottom">2008<hr/></td>
              <td align="center" valign="bottom">47<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Uncinate process/NR<hr/></td>
              <td align="left" valign="bottom">2.4<hr/></td>
              <td align="left" valign="bottom">3; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">NA<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Yang et al. [<xref ref-type="bibr" rid="B17">17</xref>]<hr/></td>
              <td align="center" valign="bottom">2008<hr/></td>
              <td align="center" valign="bottom">55<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Body and Tail/DP&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">NR<hr/></td>
              <td align="left" valign="bottom">NR; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">Relapse, 24,- A, NED,41<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Harindhanavudhi et al. [<xref ref-type="bibr" rid="B18">18</xref>]<hr/></td>
              <td align="center" valign="bottom">2008<hr/></td>
              <td align="center" valign="bottom">63<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Body/Cystojejunostomy&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">16<hr/></td>
              <td align="left" valign="bottom">&lt;5; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">NA<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Trablesi et al. [<xref ref-type="bibr" rid="B19">19</xref>]<hr/></td>
              <td align="center" valign="bottom">2009<hr/></td>
              <td align="center" valign="bottom">52<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Head/PD<hr/></td>
              <td align="left" valign="bottom">10.5<hr/></td>
              <td align="left" valign="bottom">6; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 10<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Goh et al. [<xref ref-type="bibr" rid="B20">20</xref>]<hr/></td>
              <td align="center" valign="bottom">2009<hr/></td>
              <td align="center" valign="bottom">58<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Head/PD<hr/></td>
              <td align="left" valign="bottom">9<hr/></td>
              <td align="left" valign="bottom">&gt;10; CD117(+); CD34 (-)<hr/></td>
              <td align="left" valign="bottom">A, NED, 60<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Padhi et al. [<xref ref-type="bibr" rid="B21">21</xref>]<hr/></td>
              <td align="center" valign="bottom">2010<hr/></td>
              <td align="center" valign="bottom">42<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Body and tail/DP<hr/></td>
              <td align="left" valign="bottom">35<hr/></td>
              <td align="left" valign="bottom">6-8; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 10<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Saif et al. [<xref ref-type="bibr" rid="B22">22</xref>]<hr/></td>
              <td align="center" valign="bottom">2010<hr/></td>
              <td align="center" valign="bottom">31<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Head/PD&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">8<hr/></td>
              <td align="left" valign="bottom">48; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">A, Relapse, 9<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Crisan et al. [<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td>
              <td align="center" valign="bottom">2010<hr/></td>
              <td align="center" valign="bottom">61<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Tail<hr/></td>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">NR<hr/></td>
              <td align="left" valign="bottom">A, NED, 3<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Joshi and Rustagi [<xref ref-type="bibr" rid="B24">24</xref>]<hr/></td>
              <td align="center" valign="bottom">2010<hr/></td>
              <td align="center" valign="bottom">84<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Whole pancreas/NOP<hr/></td>
              <td align="left" valign="bottom">34<hr/></td>
              <td align="left" valign="bottom">NR; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">Dead day 5 of admission<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Rao et al. [<xref ref-type="bibr" rid="B25">25</xref>]<hr/></td>
              <td align="center" valign="bottom">2011<hr/></td>
              <td align="center" valign="bottom">40<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Head and body/PD&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">6.5<hr/></td>
              <td align="left" valign="bottom">8-10; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">Relapse, 24; A, NED 30<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Cecka et al. [<xref ref-type="bibr" rid="B26">26</xref>]<hr/></td>
              <td align="center" valign="bottom">2011<hr/></td>
              <td align="center" valign="bottom">74<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Tail/DP<hr/></td>
              <td align="left" valign="bottom">11<hr/></td>
              <td align="left" valign="bottom">&lt;5; CD117(+)CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 66<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Vij et al. [<xref ref-type="bibr" rid="B27">27</xref>]<hr/></td>
              <td align="center" valign="bottom">2011<hr/></td>
              <td align="center" valign="bottom">35<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Head/PD&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">6.5<hr/></td>
              <td align="left" valign="bottom">12-15; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">Relapse, 24; A, NED 48<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Soufi et al. [<xref ref-type="bibr" rid="B28">28</xref>]<hr/></td>
              <td align="center" valign="bottom">2012<hr/></td>
              <td align="center" valign="bottom">39<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Head/PD&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">9<hr/></td>
              <td align="left" valign="bottom">5; CD117(+) CD34(+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 24<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Kim et al. [<xref ref-type="bibr" rid="B29">29</xref>]<hr/></td>
              <td align="center" valign="bottom">2012<hr/></td>
              <td align="center" valign="bottom">55<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="left" valign="bottom">Tail/DP&#x2009;+&#x2009;Imatinib<hr/></td>
              <td align="left" valign="bottom">15.8<hr/></td>
              <td align="left" valign="bottom">7; CD117(+) CD34(-)<hr/></td>
              <td align="left" valign="bottom">A, NED, 4<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Babu et al. [<xref ref-type="bibr" rid="B30">30</xref>]<hr/></td>
              <td align="center" valign="bottom">2012<hr/></td>
              <td align="center" valign="bottom">55<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="left" valign="bottom">Head/local resection<hr/></td>
              <td align="left" valign="bottom">5<hr/></td>
              <td align="left" valign="bottom">6-8; CD117(+); CD34 (+)<hr/></td>
              <td align="left" valign="bottom">A, NED, 11<hr/></td>
            </tr>
            <tr>
              <td align="left">Present case</td>
              <td align="center">2013</td>
              <td align="center">63</td>
              <td align="center">F</td>
              <td align="left">Uncinate process/enucleation</td>
              <td align="left">2.4</td>
              <td align="left">1; CD117(+)</td>
              <td align="left">A, NED, 6</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>A&#x2009;=&#x2009;alive; DP&#x2009;=&#x2009;distal pancreatectomy; NA&#x2009;=&#x2009;not available; NED&#x2009;=&#x2009;not evidence of disease; NOP&#x2009;=&#x2009;not operated; NR&#x2009;=&#x2009;not reported; PD&#x2009;=&#x2009;pancreaticoduodenectomy.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>The clinical presentation of EGISTs is variable, depending on the location and size of the tumors. The tumor may even be found incidentally. The most frequent clinical symptoms are: abdominal pain, ileus, bleeding, anemia, and weight loss. Our patient presented with a small, solid, hyperintense lesion resembling a neuroendocrine tumor. A similar finding of small, solid tumor in the uncinate process of the pancreas was reported by Yan et al. [<xref ref-type="bibr" rid="B16">16</xref>] in a case of GIST diagnosed by EUS fine-needle aspiration (FNA): unfortunately, biopsy was not available for our patient. Interestingly, 50% (11/21) of the reported cases showed radiologic features of heterogeneously mass (necrotic areas) or solid-cystic appearance; thus, problems in differential diagnosis with cystic neoplasms of the pancreas could be arise. The accuracy of CT determination of the pathological diagnosis of a pancreatic cystic lesion is less than 50% [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>], but endoscopic ultrasound-guided FNA may be helpful for the diagnosis of pancreatic lesions [<xref ref-type="bibr" rid="B36">36</xref>]. The diagnosis of GIST is based on histological, immunohistochemical, and molecular features. Microscopically, this tumor, consisted of spindle cell and epithelioid cells. The cytologic differential diagnosis for these spindle cell proliferations includes leiomyoma, schwannoma, fibromatosis, inflammatory fibroid polyps, and gastrointestinal muscularis sampling [<xref ref-type="bibr" rid="B16">16</xref>]. Immunoistochemical positivity of CD117 confirms the diagnosis of GIST. GISTs exhibit a broad spectrum of clinical behaviors, with some low-risk lesions remaining stable for years, while others progress rapidly to metastatic disease. Various parameters are proposed to predict the malignant potential of GIST, such as tumor size, mitotic activity, tumor location, non-radical resection, tumor rupture, peritoneal dissemination, metastasis, and invasion into adjacent organs. National Institute of Health (NIH) consensus criteria (Fletcher&#x2019;s criteria) [<xref ref-type="bibr" rid="B37">37</xref>] proposed risk stratification of tumor behavior into risk categories of very low, low, intermediate, and high risk of metastasis, based on its size and mitotic activity. Tumors larger than 10&#xA0;cm in size and with more than 10 mitoses per 50 HPF are at high risk of aggressive behavior [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. Standard treatment for primary GIST is complete surgical resection with the aim to obtain negative microscopic margins of resection [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. Lymphatic spread of GISTs is uncommon; therefore, a systematic lymph node dissection is not a standard surgical management. In our patient we performed a simple tumor&#x2019;s enucleation because of a preoperative diagnosis of neuroendocrine tumor. However, after discussion with oncologists, the small size of the lesion and the low-risk according to previously reported prognostic criteria [<xref ref-type="bibr" rid="B37">37</xref>], suggested that it was an adequate operation, as reported in a recent study [<xref ref-type="bibr" rid="B40">40</xref>]. The patient is alive and free of disease 1&#xA0;year after operation. The surgical management may offer primary surgery at the time of diagnosis, neoadjuvant chemotherapy followed by surgery, adjuvant therapy after surgery, or debulking surgery in patients with metastatic or advanced disease. Observation only was recommended in case with R0 resection or low-risk GIST. In recent decades, medical therapy for GIST is improved (Imatinib, Sunitinib, Nilotinib, Sorafenib, Dovitinib, and so on) and consequently disease-free survival after surgery is also much improved: in fact, it is recommended in patients with R1 or R2 resection [<xref ref-type="bibr" rid="B41">41</xref>]. The results of some clinical trials [<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B49">49</xref>] with targeted therapy of GIST are reported in Table&#xA0;<xref ref-type="table" rid="T2">2</xref>. Obviously, data about targeted therapy for EGIST are limited. In the review of the literature, among 19 high-risk EGISTs, only nine cases (47%) received adjuvant Imatinib therapy (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>).</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Selected agents investigated in the management of GIST</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Author</bold>
              </th>
              <th align="center">
                <bold>Year</bold>
              </th>
              <th align="center">
                <bold>Pts (</bold>
                <bold>
<italic>n</italic>
</bold>
                <bold>)</bold>
              </th>
              <th align="center">
                <bold>Phase study</bold>
              </th>
              <th align="left">
                <bold>Treatment</bold>
              </th>
              <th align="left">
                <bold>End point</bold>
              </th>
              <th align="left">
                <bold>Outcome (% or median)</bold>
              </th>
              <th align="left">
                <bold>
<italic>P </italic>
</bold>
                <bold>value</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Demetri et al. [<xref ref-type="bibr" rid="B42">42</xref>]<hr/></td>
              <td align="center" valign="bottom">2002<hr/></td>
              <td align="center" valign="bottom">147<hr/></td>
              <td align="center" valign="bottom">II<hr/></td>
              <td align="left" valign="bottom">Imatinib<hr/></td>
              <td align="left" valign="bottom">OR<hr/></td>
              <td align="left" valign="bottom">81.6%<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Demetri GD et al. [<xref ref-type="bibr" rid="B43">43</xref>]<hr/></td>
              <td align="center" valign="bottom">2006<hr/></td>
              <td align="center" valign="bottom">312<hr/></td>
              <td align="center" valign="bottom">III<hr/></td>
              <td align="left" valign="bottom">Sunitinib/placebo<hr/></td>
              <td align="left" valign="bottom">TTP<hr/></td>
              <td align="left" valign="bottom">27.3 <italic>vs.</italic> 5.4&#xA0;weeks<hr/></td>
              <td align="left" valign="bottom">&lt;0.0001<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="left" valign="top">Blanke et al. [<xref ref-type="bibr" rid="B44">44</xref>]<hr/></td>
              <td rowspan="2" align="center" valign="top">2008<hr/></td>
              <td rowspan="2" align="center" valign="top">746<hr/></td>
              <td rowspan="2" align="center" valign="top">III<hr/></td>
              <td align="left" valign="bottom">Imatinib 400&#xA0;mg/<hr/></td>
              <td align="left" valign="bottom">PFS<hr/></td>
              <td align="left" valign="bottom">18 <italic>vs.</italic> 20&#xA0;months<hr/></td>
              <td align="left" valign="bottom">0.13<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Imatinib 800&#xA0;mg<hr/></td>
              <td align="left" valign="bottom">OS<hr/></td>
              <td align="left" valign="bottom">55 <italic>vs.</italic> 51&#xA0;months<hr/></td>
              <td align="left" valign="bottom">0.83<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">De Matteo et al. [<xref ref-type="bibr" rid="B45">45</xref>]<hr/></td>
              <td align="center" valign="bottom">2009<hr/></td>
              <td align="center" valign="bottom">713<hr/></td>
              <td align="center" valign="bottom">III<hr/></td>
              <td align="left" valign="bottom">Imatinib/placebo<hr/></td>
              <td align="left" valign="bottom">PFS<hr/></td>
              <td align="left" valign="bottom">98% <italic>vs.</italic> 83%<hr/></td>
              <td align="left" valign="bottom">&lt;0.0001<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Dubreuil et al. [<xref ref-type="bibr" rid="B46">46</xref>]<hr/></td>
              <td align="center" valign="bottom">2009<hr/></td>
              <td align="center" valign="bottom">30<hr/></td>
              <td align="center" valign="bottom">II<hr/></td>
              <td align="left" valign="bottom">Masitinib<hr/></td>
              <td align="left" valign="bottom">PFS<hr/></td>
              <td align="left" valign="bottom">165.2&#xA0;weeks<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Sawaki et al. [<xref ref-type="bibr" rid="B47">47</xref>]<hr/></td>
              <td align="center" valign="bottom">2011<hr/></td>
              <td align="center" valign="bottom">35<hr/></td>
              <td align="center" valign="bottom">II<hr/></td>
              <td align="left" valign="bottom">Nilotinib<hr/></td>
              <td align="left" valign="bottom">PFS<hr/></td>
              <td align="left" valign="bottom">16&#xA0;weeks<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="left" valign="top">Park et al. [<xref ref-type="bibr" rid="B48">48</xref>]<hr/></td>
              <td rowspan="2" align="center" valign="top">2011<hr/></td>
              <td rowspan="2" align="center" valign="top">31<hr/></td>
              <td rowspan="2" align="center" valign="top">II<hr/></td>
              <td rowspan="2" align="left" valign="top">Sorafenib<hr/></td>
              <td align="left" valign="bottom">PFS<hr/></td>
              <td align="left" valign="bottom">4.9&#xA0;months<hr/></td>
              <td rowspan="2" align="left" valign="top">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">OS<hr/></td>
              <td align="left" valign="bottom">9.7&#xA0;months<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Joensuu et al. [<xref ref-type="bibr" rid="B49">49</xref>]<hr/></td>
              <td align="center" valign="bottom">2012<hr/></td>
              <td align="center" valign="bottom">400<hr/></td>
              <td align="center" valign="bottom">III<hr/></td>
              <td align="left" valign="bottom">Imatinib 12mo/36mo<hr/></td>
              <td align="left" valign="bottom">RFS &amp; OS<hr/></td>
              <td align="left" valign="bottom">65.6% <italic>vs.</italic> 47.9%<hr/></td>
              <td align="left" valign="bottom">&lt;0.0001<hr/></td>
            </tr>
            <tr>
              <td align="left">&#xA0;</td>
              <td align="center">&#xA0;</td>
              <td align="center">&#xA0;</td>
              <td align="center">&#xA0;</td>
              <td align="left">&#xA0;</td>
              <td align="left">&#xA0;</td>
              <td align="left">92.0% <italic>vs.</italic> 81.7%</td>
              <td align="left">0.019</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>OR&#x2009;=&#x2009;overall response; OS&#x2009;=&#x2009;overall survival; PFS&#x2009;=&#x2009;progression-free survival; RFS&#x2009;=&#x2009;recurrence-free survival; TTP&#x2009;=&#x2009;time to tumor progression.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In conclusion, we report a new case of EGIST arising from the pancreas, misinterpreted as neuroendocrine tumor. Despite its rarity, GIST should be kept in mind in the differential diagnosis of primary tumors of the pancreas, especially when a hypervascular lesion, solid or cystic, is lacking somatostatin receptors at PET examination. Radical resection of pancreatic GISTs is the treatment of choice, and repeat surgery for recurrence may offer a prolonged survival.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying image. A copy of the written consent is available for review by the Editor-in-Chief of this Journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>VB and CS conceived the study, carried out the literature search, and drafted the manuscript; MG and DP helped in management of the patient; SP carried out the pathologic diagnosis and immunoassays; SM made critical revisions and supervision. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgment</title>
      <p>We thank Ms Flavia Trabuio for her excellent help in the preparation of the manuscript.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beham</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Scheefer</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Schuler</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ghadimi</surname>
            <given-names>BM</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors</article-title>
          <source>Int J Colorectal Dis</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>689</fpage>
          <lpage>700</lpage>
          <pub-id pub-id-type="doi">10.1007/s00384-011-1353-y</pub-id>
          <pub-id pub-id-type="pmid">22124674</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kindblom</surname>
            <given-names>L-G</given-names>
          </name>
          <name>
            <surname>Remotti</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Aldenborg</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Meis-Kindblom</surname>
            <given-names>JM</given-names>
          </name>
          <article-title>Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cell of Cajal</article-title>
          <source>Am J Pathol</source>
          <year>1998</year>
          <volume>152</volume>
          <fpage>1259</fpage>
          <lpage>1269</lpage>
          <pub-id pub-id-type="pmid">9588894</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sircar</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hewlett</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Huizinga</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Chorneyko</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Berezin</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ridell</surname>
            <given-names>RH</given-names>
          </name>
          <article-title>Interstitial cell of Cajal as precursor of gastrointestinal stromal tumors</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>377</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199904000-00002</pub-id>
          <pub-id pub-id-type="pmid">10199467</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Robinson</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Sircar</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hewlett</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Chorneyko</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Riddel</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Huizinga</surname>
            <given-names>JD</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors may originate from a subset of CD34-positiva interstitial cells of Cajal</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>156</volume>
          <fpage>1157</fpage>
          <lpage>1163</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64984-X</pub-id>
          <pub-id pub-id-type="pmid">10751339</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beham</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schaefer</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>von Hammerstein</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fuzesi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramadori</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ghadimi</surname>
            <given-names>MB</given-names>
          </name>
          <article-title>Duodenal GIST: a single center experience</article-title>
          <source>Int J Colorectal Dis</source>
          <year>2013</year>
          <volume>28</volume>
          <fpage>581</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="doi">10.1007/s00384-012-1432-8</pub-id>
          <pub-id pub-id-type="pmid">22350270</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buchs</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Bucher</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gervaz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ostermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pugin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Morel</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Segmental duodenectomy for gastrointestinal tumor stromal tumor of the duodenum</article-title>
          <source>World J Gastroenterol</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>2788</fpage>
          <lpage>2792</lpage>
          <pub-id pub-id-type="doi">10.3748/wjg.v16.i22.2788</pub-id>
          <pub-id pub-id-type="pmid">20533599</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miettinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kopczynski</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Makhlouf</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gyorffy</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Burke</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sobin</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Lasota</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2003</year>
          <volume>27</volume>
          <fpage>625</fpage>
          <lpage>631</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200305000-00006</pub-id>
          <pub-id pub-id-type="pmid">12717247</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Reith</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Goldblum</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Lyles</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>SW</given-names>
          </name>
          <article-title>Extragastrintestinal (soft tissue) stromal tunor s: an analysis of 48 cases with emphasis on histologic predictors of outcome</article-title>
          <source>Mod Pathol</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>577</fpage>
          <lpage>585</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.3880099</pub-id>
          <pub-id pub-id-type="pmid">10824931</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miettinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lasota</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors: pathology and prognosis at different sites</article-title>
          <source>Semin Diagn Pathol</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>70</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1053/j.semdp.2006.09.001</pub-id>
          <pub-id pub-id-type="pmid">17193820</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Miettinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Monihan</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kovatich</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Carr</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Emory</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Sobin</surname>
            <given-names>LH</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunoistochemical study of 26 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>1109</fpage>
          <lpage>1118</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-199909000-00015</pub-id>
          <pub-id pub-id-type="pmid">10478672</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Neto</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Machuca</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Pinho</surname>
            <given-names>RV</given-names>
          </name>
          <name>
            <surname>Yuasa</surname>
            <given-names>LD</given-names>
          </name>
          <name>
            <surname>Bleggi-Torres</surname>
            <given-names>LF</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumor: report of two unusual cases</article-title>
          <source>Virchows Arch</source>
          <year>2004</year>
          <volume>444</volume>
          <fpage>594</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">15118853</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mijazawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Haba</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Muramatsu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Miyata</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Koide</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Stromal tumor of the pancreas with expression of c-kit protein: report of a case</article-title>
          <source>J Gastrointestinal Hepatol</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>467</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1746.2003.02891.x</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krska</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Peskov&#xE0;</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Povysil</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Horejs</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sedl&#xE0;ckov&#xE0;</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kudrnov&#xE0;</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>GIST of pancreas</article-title>
          <source>Prague Med Rep</source>
          <year>2005</year>
          <volume>106</volume>
          <fpage>201</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">16315768</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Daum</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Klecka</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ferda</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Treska</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Vanecek</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sima</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mukensnabi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Michal</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumor of the pancreas: Case report with documentation of KIT gene mutation</article-title>
          <source>Virchows Arch</source>
          <year>2005</year>
          <volume>446</volume>
          <fpage>470</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-004-1200-4</pub-id>
          <pub-id pub-id-type="pmid">15756592</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Showalter</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Loyd</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Glassman</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>AC</given-names>
          </name>
          <article-title>Extra-intestinal stromal tumor of the pancreas: case report and a review of the literature</article-title>
          <source>Arch Surg</source>
          <year>2008</year>
          <volume>143</volume>
          <fpage>305</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="doi">10.1001/archsurg.2007.68</pub-id>
          <pub-id pub-id-type="pmid">18347279</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yan</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Pai</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Dam</surname>
            <given-names>JV</given-names>
          </name>
          <article-title>Diagnosis of pancreatic gastrointestinal stromal tumor by EUS guided FNA</article-title>
          <source>JOP</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>192</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">18326928</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>Q</given-names>
          </name>
          <article-title>Extra-gastrointestinal stromal tumor of the pancreas: Clinical characteristics, diagnosis, treatment, and outcome</article-title>
          <source>J Surg Oncol</source>
          <year>2011</year>
          <volume>103</volume>
          <fpage>739</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.21833</pub-id>
          <pub-id pub-id-type="pmid">21240986</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Harindhanavdhi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tanawuttiwat</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pyle</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sillva</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Extra-gastrointestinal stromal tumor presenting as hemorrhagic pancreatic cyst diagnosed by EUS-FNA</article-title>
          <source>JOP</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>189</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">19287116</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Trabelsi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yacoub-Abid</surname>
            <given-names>LB</given-names>
          </name>
          <name>
            <surname>Mtimed</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ben Abdelkrim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hammedi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ben Ali</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mokni</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumor of the pancreas. A case report and review of the literature</article-title>
          <source>North Am J Med Sci</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>234</fpage>
          <lpage>236</lpage>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Goh</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Kesavan</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Wonk</surname>
            <given-names>WK</given-names>
          </name>
          <article-title>An unusual cause of pancreatic head tumor</article-title>
          <source>Gastroenterology</source>
          <year>2009</year>
          <volume>137</volume>
          <fpage>e5</fpage>
          <lpage>e6</lpage>
          <pub-id pub-id-type="pmid">19567238</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Padhi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kongara</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Uppin</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Prayaga</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Challa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Nagari</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Regulagadda</surname>
            <given-names>SA</given-names>
          </name>
          <article-title>Extra-gastrointestinal stromal tumors arising in the pancreas: a case report with a review of the literature</article-title>
          <source>JOP</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>244</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">20442520</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Saif</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Hotchikiss</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaley</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors of the pancreas</article-title>
          <source>JOP</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>405</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="pmid">20601822</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Crisan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nicoara</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cucui</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Cornea</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Laza</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Prolonged fever associated with gastrointestinal stromal tumor-case report</article-title>
          <source>J Exp Med Surg Res</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>219</fpage>
          <lpage>224</lpage>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Joshi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rustagi</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Pancreatic extra-gastrointestinal stromal tumor: an unusual presentation of a rare diagnosis</article-title>
          <source>Gastrointest Cancer Res</source>
          <year>2010</year>
          <volume>Suppl 1</volume>
          <fpage>S29</fpage>
          <lpage>S30</lpage>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rao</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Vij</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Singla</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Malignant pancreatic extra-gastrointestinal stromal tumor diagnosed by ultrasound fine needle aspiration cytology. A case report with a review of literature</article-title>
          <source>JOP</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>283</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">21546710</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cecka</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>John</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ferko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Subrt</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Nioliv</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Tycova</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Long term survival of a patient after resection of gastrointestinal stromal tumor arising from the pancreas</article-title>
          <source>Hepatobiliry Pancreat Dis Int</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>330</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="doi">10.1016/S1499-3872(11)60056-8</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vij</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Agrawal</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Pandey</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature</article-title>
          <source>JOP</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>200</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">21386653</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soufi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bouziane</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Massrouri</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chad</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Pancreatic GIST with pancreas divisum: a new entity</article-title>
          <source>Int J SurgCase Rep</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>68</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijscr.2012.09.007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Koh</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Seoung</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Hur</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>CK</given-names>
          </name>
          <article-title>Primary extragastrointestinal stromal tumor arising in the pancreas: report of a case</article-title>
          <source>Surg Today</source>
          <year>2012</year>
          <volume>42</volume>
          <fpage>386</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="doi">10.1007/s00595-011-0080-x</pub-id>
          <pub-id pub-id-type="pmid">22258729</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Babu</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Kumari</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Extragastrointestinal stromal tumor arising in the pancreas: a case report and literature review</article-title>
          <source>J Gastroenterol Hepatol Res</source>
          <year>2012</year>
          <volume>1</volume>
          <fpage>80</fpage>
          <lpage>83</lpage>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yamamoto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Oda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kawaguchi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Takahira</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tamiya</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saito</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Oshiro</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ohta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tsuneyoshi</surname>
            <given-names>M</given-names>
          </name>
          <article-title>C-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue)</article-title>
          <source>Am J Surg Pathol</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>479</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200404000-00007</pub-id>
          <pub-id pub-id-type="pmid">15087667</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="book">
          <name>
            <surname>Sobin</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Gospodarovicz</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Wittekind</surname>
            <given-names>C</given-names>
          </name>
          <source>UICC TNM Clasification of malignant tumours</source>
          <year>2009</year>
          <edition>7</edition>
          <publisher-name>Hoboken, NJ: Wiley-Blackwell</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Agaimy</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumors (GIST) from risk stratification system to the new TNM proposal: more question and answers? A review emphasizing the need for a standardization GIST reporting</article-title>
          <source>Int J Clin Exp Pathol</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>461</fpage>
          <lpage>471</lpage>
          <pub-id pub-id-type="pmid">20606727</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Visser</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Qayyum</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Way</surname>
            <given-names>LW</given-names>
          </name>
          <name>
            <surname>McCulloch</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Coakley</surname>
            <given-names>FV</given-names>
          </name>
          <article-title>Characterization of cystic pancreatic masses: relative accuracy of CT and MRI AJR</article-title>
          <source>Am J Roentgenol</source>
          <year>2007</year>
          <volume>189</volume>
          <fpage>648</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="doi">10.2214/AJR.07.2365</pub-id>
          <pub-id pub-id-type="pmid">17715113</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lee</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>KA</given-names>
          </name>
          <article-title>Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions</article-title>
          <source>Clin Radiol</source>
          <year>2011</year>
          <volume>66</volume>
          <fpage>315</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="doi">10.1016/j.crad.2010.06.019</pub-id>
          <pub-id pub-id-type="pmid">21356393</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Akahoshi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sumida</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Matsui</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Oya</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Akinaga</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kubokawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Motomura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Honda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nagaie</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Preoperative diagnosis of gastrointestinal stromal tumour by endoscopic ultrasound-guided fine needle aspiration</article-title>
          <source>World J Gastroenterol</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>2077</fpage>
          <lpage>2082</lpage>
          <pub-id pub-id-type="pmid">17465451</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Berman</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Corless</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gorstein</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lasota</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Longley</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Miettinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>O&#x2019;Leary</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Remotti</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rubin</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Shmookler</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sobin</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>SW</given-names>
          </name>
          <article-title>Diagnosis of gastrointestinal stromal tumors; a consensus approach</article-title>
          <source>Hum Pathol</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>459</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="doi">10.1053/hupa.2002.123545</pub-id>
          <pub-id pub-id-type="pmid">12094370</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gervaz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Huber</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Morel</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Surgical management of gastrointestinal stromal tumors</article-title>
          <source>Br J Surg</source>
          <year>2009</year>
          <volume>96</volume>
          <fpage>567</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="doi">10.1002/bjs.6601</pub-id>
          <pub-id pub-id-type="pmid">19434705</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Golpadas</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Toedter</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Dorman</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Rohatgi</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Gastrointestinal stromal tumor of the pancreatoduodenal complex: a detailed review and development of new prognostic scoring system</article-title>
          <source>Cancer Ther</source>
          <year>2008</year>
          <volume>6</volume>
          <fpage>577</fpage>
          <lpage>596</lpage>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhou</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum</article-title>
          <source>World J Gastroenterol</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>196</fpage>
          <lpage>201</lpage>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>VonMehren</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Antonescu</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>DeMatteo</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Ganjoo</surname>
            <given-names>KN</given-names>
          </name>
          <name>
            <surname>Maki</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Pisters</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Raut</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Riedel</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Schuetze</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sundar</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Trent</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Wayne</surname>
            <given-names>JD</given-names>
          </name>
          <article-title>NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors</article-title>
          <source>J Natl Compr Canc Net</source>
          <year>2010</year>
          <volume>8</volume>
          <fpage>S1</fpage>
          <lpage>S41</lpage>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Mehren von</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blanke</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Van den Abbeele</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Eisemberg</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Heinrich</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Tuveson</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Singer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Janicek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Silverman</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Silberman</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Capdeville</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kiese</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dimitrijevic</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Druker</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Corless</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Joensuu</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Efficacy and safety of Imatinib mesylate in advanced gastrointestinal stromal tumor</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>347</volume>
          <fpage>472</fpage>
          <lpage>480</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa020461</pub-id>
          <pub-id pub-id-type="pmid">12181401</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Oosterom Van</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Garrett</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Blackstein</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Shah</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Verweij</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>McArthur</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Judson</surname>
            <given-names>IR</given-names>
          </name>
          <name>
            <surname>Heinrich</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Desai</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>George</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bello</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Baum</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Casali</surname>
            <given-names>PG</given-names>
          </name>
          <article-title>Efficacy and safety of Sunitinib in patients with advanced gastrointestinal stromal tumour after failure of Imatinib: a randomized controlled trial</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <volume>368</volume>
          <fpage>1329</fpage>
          <lpage>1338</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(06)69446-4</pub-id>
          <pub-id pub-id-type="pmid">17046465</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Blanke</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Rankin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>von Mehren</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Benjamin</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Bramwell</surname>
            <given-names>VH</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Maki</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hecht</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Heinrich</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Crowley</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Borden</surname>
            <given-names>EC</given-names>
          </name>
          <article-title>Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase. S0033</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>626</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.13.4452</pub-id>
          <pub-id pub-id-type="pmid">18235122</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dematteo</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Ballman</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Antonescu</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Maki</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Pisters</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Demetri</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Blackstein</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Blanke</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>von Mehren</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brennan</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>McCarter</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Polikoff</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>BR</given-names>
          </name>
          <name>
            <surname>Owzar</surname>
            <given-names>K</given-names>
          </name>
          <collab>American School of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team</collab>
          <article-title>Adjuvant Imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, dowble-blind, placebo-controlled trial</article-title>
          <source>Lancet</source>
          <year>2009</year>
          <volume>373</volume>
          <fpage>1097</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60500-6</pub-id>
          <pub-id pub-id-type="pmid">19303137</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dubreuil</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Letard</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ciufolini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gros</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Humbert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cast&#xE9;ran</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Borge</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hajem</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lermet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sippl</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Voisset</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Arock</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Auclair</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Leventhal</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Mansfield</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Moussy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hermine</surname>
            <given-names>O</given-names>
          </name>
          <article-title>Masitinib (AB 1010) A potent and selective tyrosine Khinase inhibitor targeting Kit</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>e7258</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0007258</pub-id>
          <pub-id pub-id-type="pmid">19789626</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sawaki</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nishida</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Doi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Komatsu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kanda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kakeji</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Onozawa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamasaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ohtsu</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Phase 2 study of Nilotinib as third-line therapy for patients with gastrointestinal stromal tumor</article-title>
          <source>Cancer</source>
          <year>2011</year>
          <volume>117</volume>
          <fpage>4633</fpage>
          <lpage>4641</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.26120</pub-id>
          <pub-id pub-id-type="pmid">21456006</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Ryu</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Ryoo</surname>
            <given-names>BY</given-names>
          </name>
          <name>
            <surname>Im</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Kwon</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>BY</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>YK</given-names>
          </name>
          <article-title>Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group</article-title>
          <source>Invest New Drugs</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>2377</fpage>
          <lpage>2383</lpage>
          <pub-id pub-id-type="doi">10.1007/s10637-012-9795-9</pub-id>
          <pub-id pub-id-type="pmid">22270258</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Joensuu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Eriksson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sundby Hall</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hartmann</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Pink</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Schutte</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ramadori</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hohenberger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Duyster</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Al-Batran</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Schlemmer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bauer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wardelmann</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sarlomo-Rikala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nilsson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sihto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Monge</surname>
            <given-names>OR</given-names>
          </name>
          <name>
            <surname>Bono</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kallio</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Vehtari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Leinonen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Alvegard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Reichardt</surname>
            <given-names>P</given-names>
          </name>
          <article-title>One vs Three years of adjuvant Imatinib for operable gastrointestinal stromal tumor: a randomized trial</article-title>
          <source>JAMA</source>
          <year>2012</year>
          <volume>307</volume>
          <fpage>1265</fpage>
          <lpage>1272</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.2012.347</pub-id>
          <pub-id pub-id-type="pmid">22453568</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
